Related Experiment Video
Updated: Jul 18, 2026
06:44
Deep Vein Thrombosis Induced by Stasis in Mice Monitored by High Frequency Ultrasonography
Published on: April 13, 2018
Platelet hyperaggregability in idiopathic recurrent deep vein thrombosis
Circulation
|April 1, 1976
Summary
Platelet hyperactivity is present in some patients with idiopathic recurrent venous thrombosis. Aspirin and dipyridamole may help treat this condition by inhibiting platelet aggregation.
Area of Science:
- Hematology
- Thrombosis Research
Background:
- Idiopathic recurrent venous thrombosis (IRVT) poses a significant clinical challenge.
- The role of platelet function in IRVT pathogenesis requires further elucidation.
Purpose of the Study:
- To investigate platelet function abnormalities in patients with IRVT.
- To identify subgroups of IRVT patients based on platelet activity.
- To assess the efficacy of antiplatelet agents in managing platelet hyperreactivity.
Main Methods:
- Platelet function tests, including spontaneous platelet aggregation and circulating platelet aggregate assessment, were performed on 30 IRVT patients.
- Platelet survival studies using 51Cr-labeled platelets were conducted in a subset of patients.
- In vitro and in vivo effects of aspirin and aspirin plus dipyridamole were evaluated.
Main Results:
- Platelet hyperactivity, evidenced by spontaneous aggregation or circulating aggregates, was detected in a significant portion of IRVT patients.
- Platelet hyperactivity correlated with shortened platelet survival.
- Aspirin inhibited spontaneous platelet aggregation, while combination therapy normalized circulating platelet aggregates.
- IRVT patients could be categorized into subgroups with and without detectable platelet abnormalities.
Conclusions:
- Platelet hyperaggregability is a relevant factor in the pathogenesis of a subset of IRVT patients.
- Antiplatelet therapy, particularly with aspirin and dipyridamole, shows potential benefit for IRVT patients with platelet hyperaggregability.
More Related Videos
Related Concept Videos
01:30Anticoagulant Drugs: Low-Molecular-Weight Heparins
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
01:22Formation of the Platelet Plug
The platelet phase, the second stage of hemostasis, commences around 15-20 seconds after an injury. It follows and overlaps with the vascular phase, during which blood vessels constrict to minimize blood loss.
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
01:24Disorders of Hemostasis
Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
01:30Venous Thrombosis I: Introduction
Venous thrombosis, the most common disorder of the veins, involves the formation of a thrombus or blood clot associated with vein inflammation. It can be classified as either superficial vein thrombosis or deep vein thrombosis.Superficial Vein Thrombosis: This involves the formation of a thrombus in a superficial vein, usually the greater or lesser saphenous vein. Though less severe than deep vein thrombosis (DVT), SVT can lead to complications if untreated.Deep Vein Thrombosis (DVT): This...
01:29Pulmonary Embolism I: Introduction
Pulmonary embolism (PE) occurs when a thrombus, fat or air embolus, amniotic fluid, or tumor tissue blocks one or more pulmonary arteries. These blockages originate in the venous system or the right side of the heart.EtiologyPE primarily arises from deep vein thrombosis (DVT) and other hypercoagulable states, such as inherited thrombophilias. Additional etiological factors include venous stasis, commonly seen in obesity, and endothelial injury from surgery and trauma. Less common causes include...
01:19Pulmonary Embolism I: Introduction
A blood clot, or thrombus, is a semi-solid mass composed of fibrin, platelets, and red blood cells. When it forms within a vessel, it can obstruct blood flow, known as thrombosis. If part of the clot detaches, it becomes an embolus that can travel and block distant vessels. When this occurs in the pulmonary arteries, it causes a condition known as pulmonary embolism (PE).Origin and ImpactMost often, the embolus originates from a thrombus in the deep veins of the lower limbs, a condition called...